Showing results (241-250 of 555) with videos related to
Sort By:
Pageof 56
Dermatology and Therapy|March 21, 2025
Psychometric Validation of the Subject Sleep Diary in Patients with Moderate-to-Severe Atopic DermatitisJonathan I Silverberg, Danielle N Rodriguez, Carla Dias-Barbosa, et al.Acta Dermato-Venereologica|January 25, 2018
Early Relief of Pruritus in Atopic Dermatitis with Crisaborole Ointment, A Non-steroidal, Phosphodiesterase 4 InhibitorGil Yosipovitch, Linda F Gold, Mark G Lebwohl, et al.Dermatitis : Contact, Atopic, Occupational, Drug|February 16, 2022
Incidence of Bacterial and Nonbacterial Conjunctivitis in Patients With Atopic Dermatitis Treated With Dupilumab: A US Multidatabase Cohort StudyMaria C Schneeweiss, Richard Wyss, Kristyn Chin, et al.Dermatitis : Contact, Atopic, Occupational, Drug|August 14, 2023
Patients' and Caregivers' Preferences for Mental Health Care and Support in Atopic DermatitisAlbert C Chong, Alan Schwartz, Jessica Lang, et al.Dermatology and Therapy|October 21, 2022
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical TrialsJonathan I Silverberg, Mark Boguniewicz, Jon Hanifin, et al.Journal of the American Academy of Dermatology|June 17, 2019
Placebo responses in randomized controlled trials for systemic therapy in atopic dermatitis: A systematic review and meta-analysisHarrison H Lee, Kevin R Patel, Supriya Rastogi, et al.Dermatitis : Contact, Atopic, Occupational, Drug|February 10, 2025
What Does Long-Term Control in Atopic Dermatitis Look Like?Shanthi Narla, Zelma C Chiesa Fuxench, Katrina Abuabara, et al.Archives of Dermatological Research|September 17, 2021
Atopic dermatitis is not associated with SARS-CoV-2 outcomesUros Rakita, Trisha Kaundinya, Armaan Guraya, et al.Dermatology and Therapy|November 5, 2022
Determining Severity Strata for Three Atopic Dermatitis Patient-Reported Outcome Questionnaires: Defining Severity Score Ranges for the Worst Pruritus Numerical Rating Scale and the Atopic Dermatitis Symptom and Impact Scales (ADerm-SS and ADerm-IS)Jonathan I Silverberg, Eric L Simpson, Brian M Calimlim, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 25, 2023
Efficacy and safety of etrasimod, a sphingosine 1-phosphate receptor modulator, in adults with moderate-to-severe atopic dermatitis (ADVISE)Jonathan I Silverberg, Robert Bissonnette, Leon Kircik, et al.Pageof 56